Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Leases (2019 - 2025)

Fortress Biotech has reported Current Leases over the past 7 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Current Leases at $2.1 million for Q4 2025, down 18.91% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 18.91% YoY), and the annual figure for FY2025 was $2.1 million, down 18.91%.
  • Current Leases for Q4 2025 was $2.1 million at Fortress Biotech, roughly flat from $2.1 million in the prior quarter.
  • Over the last five years, Current Leases for FBIO hit a ceiling of $2.6 million in Q4 2024 and a floor of $1.8 million in Q1 2021.
  • Median Current Leases over the past 5 years was $2.2 million (2022), compared with a mean of $2.3 million.
  • Biggest five-year swings in Current Leases: grew 20.62% in 2021 and later decreased 18.91% in 2025.
  • Fortress Biotech's Current Leases stood at $2.1 million in 2021, then grew by 16.3% to $2.4 million in 2022, then increased by 3.11% to $2.5 million in 2023, then rose by 3.96% to $2.6 million in 2024, then decreased by 18.91% to $2.1 million in 2025.
  • The last three reported values for Current Leases were $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.